Cell (1)
Launched (1)
Human (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
CHEK-ATF094 | HEK293 | Human IL-31 RA/OSMR (Luc) HEK293 Reporter Cell |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| 99mTccAbVCAM1‐5 | 99mTccAbVCAM1‐5 | Phase 1 Clinical | Medico-Economic Evaluation Unit , University Hospital, Grenoble | Atherosclerosis | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Tocopherol acetate | DSE-9912 | Approved | National Institute Of Diabetes And Digestive And Kidney Diseases | Ephynal, Aquasol E | Japan | Vitamin E Deficiency; Atherosclerosis; Venous Thromboembolism; Thrombosis; Intermittent Claudication; Diabetic Retinopathy | Eisai Co Ltd | 1951-09-01 | Atherosclerosis; Venous Thromboembolism; Intermittent Claudication; Metabolic Dysfunction-Associated Steatotic Liver Disease; Vitamin E Deficiency; Thrombosis; Diabetic Retinopathy | Details |
| Ascorbic Acid/Biotin/Cholecalciferol/Cyanocobalamin/Dexpanthenol/Folic acid/Niacinamide/Pyridoxine/Riboflavin/Thiamine/Tocopherol Acetate/Vitamin A/Vitamin K | Approved | Sandoz Canada Inc | Infuvite Pediatric | United States | Avitaminosis | Sandoz Canada Inc | 2001-02-21 | Avitaminosis | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



